Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency
Cad. Saúde Pública (Online); 38 (7), 2022
Off-label use of azithromycin, hydroxychloroquine, and ivermectin (the "COVID kit") has been suggested for COVID-19 treatment in Brazil without clinical or scientific evidence of efficacy. These drugs have known adverse drug reactions (ADR). This study aimed to analyze if the sales of drugs in the "COVID...
Azitromicina/efectos adversos, Brasil/epidemiología, COVID-19/tratamiento farmacológico, Infecciones por Coronavirus/tratamiento farmacológico, Infecciones por Coronavirus/epidemiología, Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología, Hidroxicloroquina/efectos adversos, Ivermectina/efectos adversos, Pandemias, Neumonía Viral/tratamiento farmacológico, Neumonía Viral/epidemiología